🔗 Permalink

Inventor profile of:

William V. Williams

City:

Havertown, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2025-10-09

Top Assignees for applications by William V. Williams

The entities that hold a legal rights for patent applications filed by inventor Williams William V.:

INCYTE CORPORATION 8 Wilmington, DE United States
INCYTE HOLDINGS CORPORATION 6 Wilmington, DE United States
THE WISTAR INSTITUTE 2 Philadelphia, PA United States
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 1 PHILADELPHIA, PA United States
The Trustees of the Universtiy of Pennsylvania 1 Philadelphia, PA United States
Incyte Holdings Comoration 1 Wilmington, DE United States

Recent patent applications by Williams William V.

William V. Williams from Havertown, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-09

US20250312279A1

Human necessities

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

#2 | 2025-02-27

US20250064746A1

Human necessities

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

#3 | 2023-05-04

US20230136579A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#4 | 2022-10-20

US20220331253A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#5 | 2022-10-13

US20220323363A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#6 | 2022-07-07

US20220211631A1

Human necessities

SUSTAINED-RELEASE DOSAGE FORMS OF RUXOLITINIB

#7 | 2021-05-06

US20210128477A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#8 | 2020-03-26

US20200093825A1

Human necessities

JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES

#9 | 2019-08-01

US20190231696A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#10 | 2017-03-30

US20170087158A1

Human necessities

JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES

#11 | 2014-05-15

US20140135350A1

Human necessities

Sustained-release dosage forms of ruxolitinib

#12 | 2012-11-29

US20120301464A1

Human necessities

JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES

#13 | 2010-05-06

US20100113416A1

Human necessities

JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES

#14 | 2006-10-05

US20060222629A1

Human necessities

Compositions and methods for delivery of genetic material

#15 | 2006-02-21

US9359975

Compositions and methods for delivery of genetic material

InventorID:

763543 ⎘